Related Experiment Videos
[Second surgical intervention for contralateral recurrence or second primary lung cancer].
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|August 1, 1989
Summary
Resection of contralateral lung cancer, including secondary primary lung cancer, is feasible with acceptable outcomes. Despite impacting pulmonary function, patients tolerated a second operation, with a 5-year survival rate of 40%.
Area of Science:
- Thoracic Surgery
- Oncology
- Pulmonary Medicine
Context:
- Contralateral lung cancer, comprising pulmonary metastases and second primary lung cancers, presents a complex surgical challenge.
- This retrospective study analyzes 7 cases of contralateral lung cancer resections following initial non-small cell lung cancer treatment.
Purpose:
- To evaluate the postoperative complications, pulmonary function, and survival rates associated with resecting contralateral lung cancer.
- To assess the feasibility and outcomes of secondary lung cancer operations in patients with a history of non-small cell lung cancer.
Summary:
- Seven patients (1.0%) with contralateral lung cancer underwent a second operation after initial non-small cell lung cancer resection (Stage I or IIIB).
- Procedures included lobectomy-lobectomy, lobectomy-segmentectomy, lobectomy-partial resection, and pneumonectomy-partial resection, with one case involving sleeve resections.
- While contralateral resection impaired pulmonary function, all patients tolerated the second surgery, achieving a 5-year survival rate of 40.0%.
Impact:
- Contralateral lung cancer resection is a viable option for selected patients, offering a chance for improved survival.
- The findings suggest that despite functional impairment, surgical intervention for contralateral lung cancer can be well-tolerated.
- This study contributes to understanding the outcomes of managing metachronous lung cancers, informing treatment strategies.